Today's Clinical Lab - News, Editorial and Products for the Clinical Laboratory

One particularly valuable source of this information for pharma, medical technology, and regulatory professionals conducting literature reviews is clinical trials data.

Unlocking Clinical Trial Data: Driving Smarter Decisions in Safety, Compliance, and Trial Design

Mirit Eldor, LLB, MBA

Learn how structured, centralized clinical data is accelerating evidence-based decisions

Women who received the self-collection kits were more than twice as likely to participate in screening compared to those who received only a telephone reminder

Mailed HPV Self-Collection Kits Improve Cervical Screening Rates

University of Texas MD Anderson Cancer Center

Study of nearly 2,500 women in Texas found self-collection tests were effective at increasing cervical cancer screening participation in underserved US population

Clinical lab decision-makers must consider rival factors for technology purchases, according to Proscia survey results.

Proscia Survey Results Indicate Strong Competing Factors Behind Lab Tech Purchases

Scott Wallask, BA

Functionality, user experience, and pricing vie for the attention of clinical laboratory buyers

Images of positive CT colonography (CTC) screening examination result in an asymptomatic 67-year-old man. Three-dimensional colon map from CTC (left image) shows the location of two sigmoid polyps that were detected (red dots). Three-dimensional endoluminal and confirmatory two-dimensional transverse CTC images show a large 1.6-cm pedunculated polyp on top row (arrow) and a 9-mm pedunculated polyp in the distal sigmoid on the bottom row (arrow). Both polyps were confirmed and resected at optical colonoscopy performed the same day (right images), avoiding the need for a second bowel preparation. The larger polyp proved to be a tubulovillous adenoma (large advanced adenoma), whereas the smaller polyp was a nonadvanced tubular adenoma. Compare this level of information of a positive CTC screening test result with a positive multitarget stool DNA test result, for which no specific information is provided.

CT Colonography Beats Stool DNA Testing for Colon Cancer Screening

Radiological Society of North America

While both screening methods were clinically effective compared to no screening, one of them led to a better reduction of colorectal cancer incidence

This breakthrough is anticipated to pave the way for next-generation non-invasive pathological diagnosis.

Researchers Develop Virtual Staining Technology for 3D Histopathology

Korea Advanced Institute of Science and Technology

The technology uses advanced optical techniques with AI-based deep learning algorithm to create realistic, virtually stained 3D images of cancer tissue without serial sectioning nor staining

Females have two X chromosomes, males have one X and one Y chromosome, and it is common for males to lose the Y chromosome in some of their cells as they age.

Loss of Y Chromosome Leads to Poor Cancer Outcomes

Cedars-Sinai Medical Center

New findings could lead to improved immunotherapy options for male patients

The LEX system supports multiplex testing for key respiratory pathogens, including Influenza A, Influenza B, and COVID-19, and is engineered to deliver PCR results in 6 to 10 minutes.

LEX Diagnostics Submits Dual Applications for FDA 510(k) Clearance and CLIA Waiver for Groundbreaking LEX VELO System

LEX Diagnostics

The VELO system is an ultrafast point-of-care molecular diagnostics platform designed to deliver highly sensitive PCR results for key respiratory pathogens directly from a swab sample in under 10 minutes

The custom solutions program aims to build new, bespoke tools and solutions that serve as a springboard for customer innovation, enabling them to design, build, test, and iterate more quickly.

Integrated DNA Technologies Installs Custom Solutions Program to Accelerate Innovation in Synthetic Biology

Integrated DNA Technologies

White glove manufacturing service aims to enhance design-build-test cycle and drive rapid innovation

Traditional quality assurance programs focus only on analytical accuracy, leaving a gap in ensuring that the results are precise and actionable for patient care. The Molecular EQA program goes beyond just accuracy to also evaluate report clarity, how quickly results are delivered, and the result interpretation.

The Future of Pathology: Integrating Molecular EQA for Improved Cancer Care

Sofia Ramirez

The Molecular EQA program ensures that biomarker testing meets the highest standards of accuracy and reliability, supporting proficiency testing as an important part of medical laboratory practice